Combining liver cancer treatments doubles survival rates, researchers find

By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news127494360.html">Combining liver cancer treatments doubles survival rates, researchers find</a></p> <p>By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.</p>